Predictive Diagnostics

Lucence’s Dr Tan Min-Han on expanding liquid biopsy and precision oncology across Asia

Greater access to genomic testing, local population data and real-world evidence will be central to widening the clinical use of liquid biopsy and precision medicine across Asian healthcare systems....

Singapore team develops machine-learning tool to predict liver cancer recurrence

The multi-omics tool combines genomic and clinical data and outperformed TNM staging in identifying patients at risk of hepatocellular carcinoma recurrence after surgery....

Care Health Insurance Urges Early Hepatitis Screening To Prevent Serious Liver Diseases

The advisory highlights India’s hepatitis burden ahead of World Hepatitis Day and urges screening, vaccination and timely treatment to prevent severe liver complications....

ALZpath Broadens Strategic Agreement with Alamar Biosciences to Advance Clinical Diagnostics for Alzheimer's Disease

Expanded collaboration grants Alamar commercial rights to utilize ALZpath's proprietary pTau217 antibody in blood-based diagnostic tests for clinical use...

Tempus Highlights AI's Role in Improving Prostate Biopsy Reporting Accuracy

Findings from the multi-center Articulate Pro study show Paige Prostate improves diagnostic consistency, accelerates turnaround times, and reduces laboratory workloads...

Co-Diagnostics completes studies for upper respiratory point-of-care PCR test

The company is preparing a dual FDA 510(k) and CLIA Waiver submission for its Flu A/B and RSV multiplex test on the Co-Dx PCR Pro platform....

Blood Test Enables Primary Care Doctors to Diagnose Alzheimer's with Specialist-Level Accuracy

A blood test for Alzheimer's disease biomarkers helped improve diagnostic accuracy among specialists and primary care physicians in a real-world study...

Cepheid study supports point-of-care molecular testing for vaginitis care

The Xpert Xpress MVP test helped more women receive appropriate treatment within 24 hours compared with usual diagnostic methods....

Beckman Coulter Diagnostics Expands Alzheimer's Portfolio with CE-Marked p-Tau217 Blood Test

CE-marked Access p-Tau217 blood test designed to support clinical evaluation of amyloid pathology in patients with signs and symptoms of cognitive decline across Europe...

Blood Test Screens Dogs for Multiple Diseases at Once, Peer-Reviewed Study Shows

The platform was built and validated specifically for dogs, and LatusPet plans to add further conditions each year, with work underway to extend it to other species...